DNA damage triggers squamous metaplasia in human lung and mammary cells via mitotic checkpoints

Fecha de publicación: Fecha Ahead of Print:

Autores de IDIVAL

  • Lucía San Juan Naharro

    Autor

  • Ana Freije Leon

    Autor

  • Natalia Sanz Gomez

    Autor

  • Beatriz Jimenez Matias

    Autor

  • Juan Ramón Sanz Giménez-Rico

    Autor

  • Ernesto De Diego García

    Autor

  • Sara Naranjo Gozalo

    Autor

  • Alberto Gandarillas Solinis

    Autor

Autores ajenos al IDIVAL

  • Cayetano Pleguezuelos Manzano
  • Hans Clevers

Unidades

Abstract

Epithelial transdifferentiation is frequent in tissue hyperplasia and contributes to disease in various degrees. Squamous metaplasia (SQM) precedes epidermoid lung cancer, an aggressive and frequent malignancy, but it is rare in the epithelium of the mammary gland. The mechanisms leading to SQM in the lung have been very poorly investigated. We have studied this issue on human freshly isolated cells and organoids. Here we show that human lung or mammary cells strikingly undergo SQM with polyploidisation when they are exposed to genotoxic or mitotic drugs, such as Doxorubicin or the cigarette carcinogen DMBA, Nocodazole, Taxol or inhibitors of Aurora-B kinase or Polo-like kinase. To note, the epidermoid response was attenuated when DNA repair was enhanced by Enoxacin or when mitotic checkpoints where abrogated by inhibition of Chk1 and Chk2. The results show that DNA damage has the potential to drive SQM via mitotic checkpoints, thus providing novel molecular candidate targets to tackle lung SCC. Our findings might also explain why SCC is frequent in the lung, but not in the mammary gland and why chemotherapy often causes complicating skin toxicity.

© 2023. The Author(s).

Datos de la publicación

ISSN/ISSNe:
2058-7716, 2058-7716

Cell Death Discovery  SPRINGERNATURE

Tipo:
Article
Páginas:
21-21
PubMed:
36681661

Citas Recibidas en Web of Science: 8

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Compartir